Platelet rich plasma is cost-effective for diabetic foot ulcers that won’t heal

Diabetic foot ulcer

This cost-utility analysis found that the plasma gel improved healing, improved quality of life and reduced costs overall. Platelet rich plasma (PRP) gel contains important compounds to stimulate wound healing. Autologous PRP gel contains elements that are derived from a patient’s own blood. Clinical question In diabetic foot ulcers that do not heal, do autologous [read the full story…]

Giving nurses more responsibility for diabetes care may improve cost-effectiveness

Enhancing the role of specialist nurses is one way to reduce cost pressures on health systems.  A recently-published study assessed the cost-effectiveness of using specialist diabetes care nurses instead of doctors to provide diabetes care. Clinical question In hospital diabetes care, does a model of care led by specialist nurses as compared with physicians, lead [read the full story…]

Insulin glargine may be cost-effective compared with basal insulin.

Picture of a syringe

Insuline glargine has several clinical and quality of life benefits compared with human basal insulin (NPH).  However, it is also more costly.  Do these benefits justify the additional cost? A new economic evaluation addresses this question.  The authors searched the literature for published evaluations.  They found seven good quality studies that addressed the issue, though [read the full story…]

In type 2 diabetes, sulphonylureas are the most cost-effective second-line treatment.


Metformin is often the first line of drug treatment for type 2 diabetes.  There is a range of options for additional treatment, should metformin alone prove insufficient to achieve adequate glyaemic control. This economic evaluation looked at the evidence on the effectiveness of these treatment options, balanced against the cost of each. They did this [read the full story…]